Singular Genomics Systems Financial Health

Short Term Liabilities: OMIC's short term assets ($286.1M) exceed its short term liabilities ($14.2M).

Long Term Liabilities: OMIC's short term assets ($286.1M) exceed its long term liabilities ($54.4M).

Debt Level: OMIC has more cash than its total debt.

Reducing Debt: Insufficient data to determine if OMIC's debt to equity ratio has reduced over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OMIC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: OMIC has sufficient cash runway for 2.8 years if free cash flow continues to reduce at historical rates of 58.1% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.